CareDx (CDNA) EBIT Margin: 2013-2025
Historic EBIT Margin for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to -0.25%.
- CareDx's EBIT Margin rose 1631.00% to -0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.66%, marking a year-over-year increase of 6981.00%. This contributed to the annual value of 12.21% for FY2024, which is 8476.00% up from last year.
- CareDx's EBIT Margin amounted to -0.25% in Q3 2025, which was up 98.08% from -12.83% recorded in Q2 2025.
- CareDx's 5-year EBIT Margin high stood at 97.46% for Q4 2024, and its period low was -187.03% during Q4 2023.
- Moreover, its 3-year median value for EBIT Margin was -16.55% (2024), whereas its average is -26.17%.
- In the last 5 years, CareDx's EBIT Margin crashed by 16,382bps in 2023 and then surged by 28,449bps in 2024.
- Quarterly analysis of 5 years shows CareDx's EBIT Margin stood at -19.44% in 2021, then crashed by 377bps to -23.21% in 2022, then plummeted by 16,382bps to -187.03% in 2023, then surged by 28,449bps to 97.46% in 2024, then surged by 1,631bps to -0.25% in 2025.
- Its EBIT Margin stands at -0.25% for Q3 2025, versus -12.83% for Q2 2025 and -15.79% for Q1 2025.